Moderna Inc. on Monday said human subjects in a Stage 1 trial of a prospect Covid-19 vaccine produced immune actions that were a favorable indication of the vaccine’s capacity to avoid infection with the brand-new coronavirus.
In the trial, people who got different dose levels of the vaccine all seroconverted within 15 days of a single dosage, which means that they produced antibodies. 2 weeks after getting a second dose, individuals who received the smallest-tested dosage of the vaccine created levels of binding antibodies comparable …
%%.
source https://jobsearchtips.net/moderna-says-preliminary-covid-19-vaccine-results-are-positive/
No comments:
Post a Comment